News

Scientists at Weill Cornell Medicine have developed a computational technique that greatly increases the resolution of atomic force microscopy, a specialized type of microscope that “feels” the atoms at a surface.

A group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell Medicine and NewYork-Presbyterian reported that the Moderna mRNA vaccine and a protein-based vaccine candidate elicited durable neutralizing antibody responses to SARS-CoV-2 in pre-clinical research.

Combining immunotherapy with targeted radiation resulted in a greater response rate than immunotherapy alone in a phase 2 clinical trial in patients with early-stage, non-small-cell lung cancer led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

Dr. Sallie Permar's research on mother-to-child transmission of viruses including HIV and cytomegalovirus (CMV), the most common congenital infection worldwide, recently earned her the prestigious 2020-21 Society of Pediatric Research Award in Honor of E. Mead Johnson.

Two gene variants found in African American women may explain why they are more likely to be diagnosed with triple negative breast cancer (TNBC) than white women of European ancestry, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.

The transition from pre- to post-menopause, with its steep decline in estrogen production, involves myriad changes to brain structure, brain-region connectivity, and brain energy consumption, though many of these changes are only temporary, a study led by researchers at Weill Cornell Medicine has found.

At Weill Cornell Medicine, a Pioneering Team Protects Victims of Elder Abuse

Women become more susceptible to hypertension as they approach menopause, and now a preclinical study led by researchers at Weill Cornell Medicine’s Feil Family Brain and Mind Research Institute suggests that this “perimenopausal” hypertension may be driven by declines in estrogen signaling in a brain region called the hypothalamus—and may be preventable with estrogen-like treatments.

Dr. Maria Paz Zafra, a postdoctoral associate in medicine at Weill Cornell Medicine, has won a 2021 Tri-Institutional Breakout Award for Junior Investigators.

Using an antibody to block HIV from infecting cells may be an effective and more convenient way to prevent acquisition of HIV, suggests a preliminary study by a multi-institution team of researchers led by investigators from Weill Cornell Medicine and Oregon Health and Science University (OHSU).

SARS-CoV-2, the virus causing the global COVID-19 pandemic, can infect human pancreatic cells and alter their physiology.

To encourage students from diverse backgrounds to join their ranks, physician-scientist communities must address the significant social, cultural and financial barriers many first-generation college students face in pursuing M.D.-Ph.D. careers, according to a new commentary authored by faculty, a student and staff in the Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional M.D.–Ph.D. Program.

Weill Cornell Medicine faculty members were honored with awards for their exemplary achievements in medical research, education and care at the institution’s virtual commencement ceremony on May 20.

Dr. Marcin Imielinski and Dr. Elena Piskounova were awarded the 2021 Pershing Square Sohn Prize for Young Investigators in Cancer Research.

Awards, honors, prizes and achievements for the month of May.

Eight Weill Cornell Medicine faculty members have received Young Physician-Scientist Awards from the American Society for Clinical Investigation (ASCI), the most awarded to any institution this year.

With in-person teaching in hospital and clinic settings suspended as the COVID-19 pandemic emerged, Weill Cornell Medical College swiftly designed innovative telehealth courses that enabled medical students to take part in remote patient care while also positioning them for post-pandemic careers with expanded digital healthcare options.

About 12,000 bacteria and viruses collected in a sampling from public transit systems and hospitals around the world from 2015 to 2017 had never before been identified.

Low levels of a clot-busting protein may explain why some people are at higher risk of blood-clotting disorders, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian investigators.

A new federal mandate that requires Medicaid to cover clinical trial costs is an important step to increase racial and ethnic minority participation in research and improve access for low-income patients to advanced treatments.